Stephen Moses
Stephen Moses, Professor, Departments of Medical Microbiology, Community Health Sciences and Medicine. Stephen Moses has been a circumcision proponent since at least 1994.[1] Moses (along with Robert C. Bailey) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)[2] which are being used by the World Health Organization (under the guide of UNAIDS) to endorse circumcision as an HIV prevention method.[3]
|
| Stephen Moses |
| Associates With: |
| Gilgal Society Circlist |
| Colleagues & Benefactors: |
| Daniel T. Halperin Edgar J. Schoen Robert C. Bailey Bertran Auvert Maria J. Wawer Brian J. Morris |
Contents
Interests
According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.[4] Moses has been an advocate of circumcision since at least 1994.[1]
RCT in Kenya
Of the three RCTs being used by the WHO to endorse circumcision as HIV prevention, Stephen Moses and Robert C. Bailey headed the RCT that was carried out in Kenya.[5] All three trials were funded by the American National Institutes of Health.[6]
Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent relative reduction in HIV was claimed, the absolute reduction was a statistically insignificant 1.3 percent.[7]
Active projects
- A randomized, controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya.[4]
National Institutes of Health. - Scaling up HIV prevention in Karnataka and southern Maharashtra, Phase II.[4]
Bill & Melinda Gates Foundation. - Monitoring and evaluation of the Avahan project in India.[4]
Bill & Melinda Gates Foundation. - Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.[4]
Bill & Melinda Gates Foundation. - Mapping key populations for HIV prevention in Sri Lanka.[4]
World Bank.
Recent publications
- Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.[8]
Smith JS, Hudgens MG, Bailey RC, Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7. - Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.[9]
Moses S. CIHR/CMAJ 2009; 181: E134-5. - Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.[10]
Mehta SD, Gray RH, Auvert B, Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, Wawer MJ, Bailey RC. AIDS 2009; 23: 1557-64. - Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.[11]
Bailey RC, Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56. - Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.[12]
Nagelkerke NJD, Moses S, de Vlas S, Bailey RC. BMC Infect Dis 2007; 7: 16. - Adult male circumcision outcomes: experience in a developing country setting.[13]
Krieger J, Bailey RC, Agot K, Parker C, Ndinya-Achola JO, Moses S, et al. Urol Int 2007; 78: 235-40.
See also
References
- ↑ a b
Moses, S., Bradley, J.E., Ndinya-Achola, J.O., Nagelkerke, N.J., Ronald, A.R.. The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis. 1994; 21: 201-210.
- ↑ Krieger, J.N., Bailey, R.C., Opeya, J., et al. Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya. BJU Int.. November 2005; 96(7): 1109–13. PMID. DOI.
- ↑
World Health Organization (27 March 2007). WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention
. Retrieved 23 February 2011. - ↑ a b c d e f Dr. Moses, Stephen. [<title> parameter missing!, University of Manitoba. Retrieved 23 February 2011.
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-56. Abstract
- ↑ (2008).
The Use of Male Circumcision to Prevent HIV Infection
, Doctors Opposing Circumcision. Retrieved 5 March 2011.
Quote:...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa.
- ↑ Boyle, Gregory J., Hill, George. Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns. J Law Med. December 2011; 19(2): 316-334. PMID. Retrieved 23 March 2020.
- ↑ Smith, J.S., Backes, D.M., Hudgens, M.G., et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int. J. Cancer. January 2010; 126(2): 572–7. PMID. PMC. DOI.
- ↑ Moses, S.. Male circumcision: a new approach to reducing HIV transmission. CMAJ. October 2009; 181(8): E134–5. PMID. PMC. DOI.
- ↑ Mehta, S.D., Gray, R.H., Auvert, B., et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS. July 2007; 23(12): 1557–64. PMID. PMC. DOI.
- ↑ Bailey, R.C., Moses, S., Parker, C.B., et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. February 2007; 369(9562): 643–56. PMID. DOI.
- ↑ Nagelkerke, N.J., Moses, S., de Vlas, S.J., Bailey, R.C.. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect. Dis.. 2007; 7: 16. PMID. PMC. DOI.
- ↑ Krieger, J.N., Bailey, R.C., Opeya, J.C., et al. Adult male circumcision outcomes: experience in a developing country setting. Urol. Int.. 2007; 78(3): 235–40. PMID. DOI.
